Sino-Agri Leading Biosciences Co.,Ltd

SSE:603970.SS

12.95 (CNY) • At close April 30, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42015 Q1
Revenue 2,080.3441,983.5744,132.6392,396.2232,088.6062,080.2573,942.2132,343.0892,014.3233,590.834,059.1072,034.5141,347.1612,597.773,056.5711,820.6091,457.9171,642.922,180.1911,359.966936.384782.9981,441.8241,181.259789.267602.451,276.881,066.029615.724614.8281,332.053940.857600.766720.673
Cost of Revenue 1,904.4051,846.1753,871.0992,231.071,878.5561,937.4663,697.122,180.2891,853.3123,385.7613,796.6831,895.3711,222.1282,479.842,875.1611,691.7251,345.5461,530.2451,982.6041,248.848849.347694.7641,284.3971,068.264699.552517.3811,141.91958.734523.994537.7551,185.112837.672522.718640.395
Gross Profit 175.94137.399261.54165.154210.05142.791245.092162.8161.011205.069262.424139.144125.033117.93181.41128.884112.371112.675197.588111.11787.03788.234157.428112.99589.71585.069134.97107.29691.7377.072146.942103.18578.04780.277
Gross Profit Ratio 0.0850.0690.0630.0690.1010.0690.0620.0690.080.0570.0650.0680.0930.0450.0590.0710.0770.0690.0910.0820.0930.1130.1090.0960.1140.1410.1060.1010.1490.1250.110.110.130.111
Reseach & Development Expenses 19.81919.59912.66913.56124.05114.60719.556.60128.3326.6257.3254.57121.9815.9746.3424.65824.2093.4794.9653.07521.2613.2997.6050.5351.6394.4657.3960.7643.742017.37601.0680.462
General & Administrative Expenses -21.89436.367-4.0679.517-34.46644.795-5.20412.643-34.72742.754-11.75815.462-35.75345.778-10.8214.662-31.19315.135-6.04412.697-28.22312.954-7.77113.463-28.79913.022-7.20912.141-25.66711.857-4.57911.711-17.5578.5
Selling & Marketing Expenses -45.028112.39972.46738.62274.08856.05762.01251.52350.84455.07467.59350.0938.24245.07456.27541.72230.1647.21561.41432.58124.57448.02749.5443.50532.5647.40754.69546.97452.30555.31860.38242.94646.1231.477
SG&A -66.922148.76694.42755.19787.456100.85256.80964.16516.11697.82855.83565.5522.48990.85245.45556.384-1.03462.3555.3745.277-3.64960.98141.7756.9693.76160.42847.48659.11526.63867.17455.80354.65728.56339.977
Other Expenses 170.175-53.271-7.251-5.723-60.266-22.66222.549-0.72259.41-30.06727.654-6.724-0.4880.2980.8380.465-5.2150.290.7640.1990.8470.236.5380.4140.0590.3690.3850.244-3.3463.996-1.5981.657.001-0.013
Operating Expenses 124.71114.426114.34774.481171.77488.732101.12170.044103.85974.38690.81463.39873.25173.72878.66959.34768.23965.94383.06349.0863.28664.00867.21860.78156.52158.67568.64659.20470.05465.16373.89155.98963.24440.024
Operating Income 51.2322.973147.19390.67238.27639.917138.65183.70844.572124.818140.6567.4226.04637.261116.74459.07543.79121.39995.96850.2639.93718.42576.74642.49926.20316.05980.58934.0917.890.95775.39428.4797.71523.459
Operating Income Ratio 0.0250.0120.0360.0380.0180.0190.0350.0360.0220.0350.0350.0330.0190.0140.0380.0320.030.0130.0440.0370.0110.0240.0530.0360.0330.0270.0630.0320.0290.0020.0570.030.0130.033
Total Other Income Expenses Net 0.017-0.112-3.639-6.917-0.096-0.067-0.622-0.071-0.015-0.4990.4060.816-0.4880.0790.8380.465-5.2150.29-8.9430.1990.8470.236.5380.4140.0590.3690.380.244-3.0213.996-1.6061.656.884-0.015
Income Before Tax 51.24722.861143.55483.50153.40739.85138.60583.63744.55771.812141.08668.23525.55837.559117.58259.5438.57621.68996.73250.46310.78318.65483.28442.91226.26216.42980.96934.33414.8694.95373.78830.12914.59823.445
Income Before Tax Ratio 0.0250.0120.0350.0350.0260.0190.0350.0360.0220.020.0350.0340.0190.0140.0380.0330.0260.0130.0440.0370.0120.0240.0580.0360.0330.0270.0630.0320.0240.0080.0550.0320.0240.033
Income Tax Expense 11.4566.35134.69820.7289.3345.87627.86424.4749.09918.19733.81816.6673.3996.53928.38316.28310.0225.28924.31912.78-6.1214.87420.10712.2852.2375.78724.65110.1692.111-0.63323.3599.2091.3967.355
Net Income 28.25817.03101.25556.83543.00729.55298.64253.63940.99153.61594.33844.52233.41825.15976.89434.83824.92414.86663.66328.9922.649.87958.23628.12224.74110.25457.08723.37717.8038.07347.02117.43315.73917.417
Net Income Ratio 0.0140.0090.0250.0240.0210.0140.0250.0230.020.0150.0230.0220.0250.010.0250.0190.0170.0090.0290.0210.0240.0130.040.0240.0310.0170.0450.0220.0290.0130.0350.0190.0260.024
EPS 0.110.0630.380.210.160.110.370.20.150.280.490.230.120.130.40.130.130.0550.330.110.120.0370.310.10.130.0380.310.110.0950.040.320.0840.110.086
EPS Diluted 0.110.0630.380.210.160.110.370.20.150.280.490.230.120.130.40.130.130.0550.330.110.120.0370.310.10.130.0380.310.110.0950.040.320.0840.110.086
EBITDA 61.60328.944155.65189.63661.53351.411147.03993.81257.81385.106148.01979.97734.54153.44129.88266.16253.03835.105107.24859.92717.425.204100.90852.52541.5627.35664.27551.93813.08516.45259.14651.94758.99741.572
EBITDA Ratio 0.030.0150.0380.0370.0290.0250.0370.040.0290.0240.0360.0390.0260.0210.0420.0360.0360.0210.0490.0440.0190.0320.070.0440.0530.0450.050.0490.0210.0270.0440.0550.0980.058